Yes Page 17 is foolproof that unblinding is in process. Also in another slide, LP said the last patient dosed was Nov 2015 and the trial has well matured. I don't understand the shorts that what more explicitly one can say to convince the trial is done unless display the numbers which is not available yet. These shorts are so nervous that any thing you tell them is not going to make them happy because they realize NWBO is not going bk for sure. See LP is here with an agenda of Go Big or Go Home. I think she is going to get us at least $50 a share by the end of 2019. ASCO will set the stage and B/O follows, imo. Like AMRN dominates the cardio field, NWBO will dominate the cancer field. Like AMRN has no competitor, NWBO will have no competitor. These two are based on Science, real science. Science never fails anywhere any time.
News 
Market Data 
Discover 
